CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (9,154,632)	$ (6,576,038)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	5,062	1,376
Stock-based compensation expense	(127,766)	406,488
Noncash lease expense	32,251	37,021
Unrealized gain on investment	(20,770)	0
Loss on equity investments in unconsolidated affiliates	3,389,503	0
Changes in operating assets and liabilities:
Other assets	919,363	(105,661)
Operating lease liabilities	(29,945)	(37,113)
Accounts payable	(539,596)	1,222,404
Accrued expenses and other current liabilities	(3,322,479)	1,834,550
Net cash used in operating activities	(8,849,009)	(3,216,973)
Cash flows from investing activities:
Capital expenditures	(5,619,034)	(5,090,488)
Advances on the Ewoyaa Project	(3,632,483)	0
Purchase of equity investments in unconsolidated affiliates	(2,046,207)	(9,316,394)
Net cash used in investing activities	(11,297,724)	(14,406,882)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	122,059,476	114,087,891
Proceeds from exercise of stock options	0	30,452
Principal payments on long-term debt	(247,234)	(182,973)
Net cash provided by financing activities	121,812,242	113,935,370
Net increase in cash	101,665,509	96,311,515
Cash and cash equivalents at beginning of period	64,244,983	70,936,994
Cash and cash equivalents at end of period	165,910,492	167,248,509
Supplemental disclosure of cash flow information:
Noncash capital expenditures in accounts payable and accrued expenses	2,421,433	0
Cash paid for interest	42,397	68,838
Capitalized stock-based compensation	$ 41,858	$ 0